Stocks Health care OCEA
OTC · Health careOcean Biomedical, Inc. (OCEA)
It posted a net loss of $30.7M. At March 31, 2025 it held $800K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on May 15, 2025.
Key facts about Ocean Biomedical, Inc.
- Net worth
- Ocean Biomedical, Inc. has a market value (market cap) of $23.2K at the latest share price, and shareholders' equity of -$92.4M on its balance sheet at March 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2024 operations used $4.2M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on May 15, 2025 and covers the period to March 31, 2025. Open on SEC EDGAR
What Ocean Biomedical, Inc. does
Ocean Biomedical, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker OCEA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2024 | n/a | -$9.5M | -$0.34 | n/a |
| 2023 | n/a | -$114.5M | -$4.35 | n/a |
| 2022 | n/a | -$17.4M | -$0.74 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Ocean Biomedical, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2025Late quarterly report notice NT 10-Q
- August 8, 2025Delisting notice 25-NSE
- August 5, 2025
- July 23, 2025
- July 16, 2025
- June 13, 2025
- May 15, 2025
- April 29, 2025
- April 23, 2025
- April 8, 2025
Insider trades
What the people running Ocean Biomedical, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Who owns OCEA
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Ayrton Capital LLC13G, passive with 2 related filers | 9.9% | February 13, 2025 |
Largest institutional holders
Insiders
Questions about OCEA
What does Ocean Biomedical, Inc. do?
Ocean Biomedical, Inc. is a company in the Health care sector, listed on OTC as OCEA. Its shares trade on OTC under the ticker OCEA.
What is Ocean Biomedical, Inc.'s net worth?
Ocean Biomedical, Inc. has a market value (market cap) of $23.2K at the latest share price, and shareholders' equity of -$92.4M on its balance sheet at March 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Ocean Biomedical, Inc. profitable?
No. Over the twelve months to March 31, 2025 it reported a net loss of $30.7M.
When did Ocean Biomedical, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on May 15, 2025. It covers the period to March 31, 2025. Its newest filing of any kind is the late quarterly report notice from August 14, 2025.
Similar companies
Compare OCEA with
Follow OCEA
Get an email when Ocean Biomedical, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Ocean Biomedical, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.